Results of a systematic review of randomised controlled trials of intravitreal bevacizumab for the treatment of diabetic macular oedema (Canadian Agency for Drugs and Technologies in Health)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
